ACKR3 and neoplasm: Furthermore, increasing evidence of tumor microenvironment controlling CXCR7 expression, particularly in the context of hypoxia, has implicated it as a promising biomarker for anti-tumor and anti-metastatic drug development (reviewed by Wang et al., 2018).